Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 3/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | CES2 | O00748 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | CES1 | P23141 | 1/20 | 0.34 |
| ▸ | MPI | P34949 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17791503 | 0.78 | LMNA (0.35) | ATMNPC1KMT2AGPR35ALDH1A1 | |
| SCHEMBL17791501 | 0.77 | POLB (0.36) | ATMNPC1KMT2AGPR35ALDH1A1 | |
| SCHEMBL16133489 | 0.77 | PTGS2 (0.36) | ATMNPC1KMT2AGPR35ALDH1A1 | |
| SCHEMBL17791507 | 0.77 | NPC1 (0.33) | ATMNPC1KMT2AGPR35ALDH1A1 | |
| SCHEMBL17794334 | 0.75 | KMT2A (0.40) | ATMNPC1KMT2AGPR35ALDH1A1 | |
| SCHEMBL22139551 | 0.73 | TDP1 (0.40) | NPC1KMT2AALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL16133488 | 0.73 | POLB (0.37) | ATMNPC1KMT2AGPR35ALDH1A1 | |
| SCHEMBL4456724 | 0.73 | ATM (0.41) | ATMNPC1KMT2AGPR35ALDH1A1 | |
| SCHEMBL16606380 | 0.72 | TRPA1 (0.41) | ATMNPC1KMT2AGPR35ALDH1A1 | |
| SCHEMBL24543911 | 0.71 | ATM (0.35) | ATMNPC1KMT2AGPR35ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10884346-B2 | Electrophotographic photosensitive member, process cartridge, and image forming apparatus | KYOCERA DOCUMENT SOLUTIONS INC. (JP) | 2021-01-05 | — | — | US | disclosed |
| US-20200201199-A1 | ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER, PROCESS CARTRIDGE, AND IMAGE FORMING APPARATUS | KYOCERA DOCUMENT SOLUTIONS INC. (JP) | 2020-06-25 | — | — | US | disclosed |
| US-9783491-B2 | Quinone derivative and electrophotographic photosensitive member | KYOCERA DOCUMENTS SOLUTIONS INC. (JP) | 2017-10-10 | — | — | US | disclosed |
| US-9783491-B2 | Quinone derivative and electrophotographic photosensitive member | KYOCERA DOCUMENTS SOLUTIONS INC. (JP) | 2017-10-10 | — | — | US | disclosed |
| US-20160152556-A1 | QUINONE DERIVATIVE AND ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER | KYOCERA DOCUMENT SOLUTIONS INC. (JP) | 2016-06-02 | — | — | US | disclosed |
| US-20160152556-A1 | QUINONE DERIVATIVE AND ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER | KYOCERA DOCUMENT SOLUTIONS INC. (JP) | 2016-06-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160152556-A1 | QUINONE DERIVATIVE AND ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER | KEAP1, RAD54L, ATXN2L | ATM 2359/4885NPC1 3820/4885KMT2A 2994/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.